Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.
Maurillo L, Buccisano F, Del Principe MI, Del Poeta G, Spagnoli A, Panetta P, Ammatuna E, Neri B, Ottaviani L, Sarlo C, Venditti D, Quaresima M, Cerretti R, Rizzo M, de Fabritiis P, Lo Coco F, Arcese W, Amadori S, Venditti A. Maurillo L, et al. Among authors: buccisano f. J Clin Oncol. 2008 Oct 20;26(30):4944-51. doi: 10.1200/JCO.2007.15.9814. Epub 2008 Jul 7. J Clin Oncol. 2008. PMID: 18606980 Free article.
Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia.
Del Principe MI, Cefalo M, Buccisano F, Anemona L, Sarlo C, Di Caprio L, De Santis G, Giacobbi E, Maurillo L, Postorino M, Del Poeta G, Amadori S, Venditti A. Del Principe MI, et al. Among authors: buccisano f. Ann Hematol. 2014 Sep;93(9):1611-2. doi: 10.1007/s00277-014-2010-7. Epub 2014 Jan 23. Ann Hematol. 2014. PMID: 24452366 No abstract available.
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy.
Postorino M, Pupo L, Provenzano I, Del Principe MI, Buccisano F, Franceschini L, Rizzo M, Nasso D, Meconi F, Onnis I, Vaccarini S, Zizzari A, Anemona L, Mauramati S, Bruno E, Cantonetti M, Amadori S. Postorino M, et al. Among authors: buccisano f. Ann Hematol. 2016 Jan;95(1):153-154. doi: 10.1007/s00277-015-2503-z. Epub 2015 Oct 7. Ann Hematol. 2016. PMID: 26442854 No abstract available.
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.
Del Poeta G, Del Principe MI, Consalvo MA, Maurillo L, Buccisano F, Venditti A, Mazzone C, Bruno A, Gianní L, Capelli G, Lo Coco F, Cantonetti M, Gattei V, Amadori S. Del Poeta G, et al. Among authors: buccisano f. Cancer. 2005 Dec 15;104(12):2743-52. doi: 10.1002/cncr.21535. Cancer. 2005. PMID: 16284990 Free article. Clinical Trial.
Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.
Del Poeta G, Ilaria Del Principe M, Buccisano F, Maurillo L, Niscola P, Venditti A, Amadori S. Del Poeta G, et al. Among authors: buccisano f. Expert Rev Anticancer Ther. 2006 Dec;6(12):1787-800. doi: 10.1586/14737140.6.12.1787. Expert Rev Anticancer Ther. 2006. PMID: 17181492 Review.
Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow.
Maurillo L, Buccisano F, Spagnoli A, Del Poeta G, Panetta P, Neri B, Del Principe MI, Mazzone C, Consalvo MI, Tamburini A, Ottaviani L, Fraboni D, Sarlo C, De Fabritiis P, Amadori S, Venditti A. Maurillo L, et al. Among authors: buccisano f. Haematologica. 2007 May;92(5):605-11. doi: 10.3324/haematol.10432. Haematologica. 2007. PMID: 17488683 Free article.
195 results